Liver transplantation: Indications, preoperative evaluation and posttransplantation management

Clinical Hepatology

Volumn 2, Issue , 2010, Pages 1353-1381

  Fink, Scott A ^a   Brown Jr , Robert S ^a  

^a Columbia University 622 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889978355     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-04519-6_49     Document Type: Chapter

References (105)

1. Abt PL, Mange KC, Olthoff KM, et al (2004) Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant 4:1302-7
2. Alamo JM, Gomez MA, Preja F, et al (2006) Morbidity and mortality in liver retransplantation. Transplant Proc 38:2475-7
3. Anderson RD, Chimakotia S, Guo K, et al (2007) Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation. Clin Transplant 21:510-7
4. Arguedas MR, Abrams GA, Krowka MJ, et al (2003) Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 37:192-7
5. Baid S, Cosimi AB, Farrell MC, et al (2001) Posttransplant diabetes mellitus in liver transplant recipients. Transplantation 72:1066-72
6. Baltz AC, Trotter JF (2003) Living donor liver transplantation and hepatitis C. Clin Liver Dis 7:651-5
7. Basse G, Esposito L, Mengelle C, et al (2006) Predictive factors for cytomegalovirus infection after OLT using an ultrasensitive polymerase chain reaction. Transpl Proc 38:2839-41
8. Bellamy CO, Di Martini AM, Ruppert K, et al (2001) Liver transplantation for alcoholic cirrhosis. Transplantation 72:619-26
9. Berg CL, Gillespie BW, Merion RM, et al (2007) Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 133:1806-13
10. Bismuth H, Majno PE, Adam R (1999) Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 19:311-22
11. Blair JE, Kusne S (2005) Bacterial, mycobacterial, and protozoal infections after liver transplantation-part I. Liver Transpl 11:1452-9
12. Brown RS, Lake JR (2005) The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution. Am J Transpl 5:203-4
13. Canzanello VI, Textor SC Taler SJ, et al (1998). Late hypertension after liver transplantation. Liver Transpl Surg 4:328-34
14. Carithers RL Jr (2000) Liver transplantation. Liver Transpl 6:122-35
15. Chahal P, Baron TH, Poterucha JJ, et al (2007) Endoscopic retrograde cholangiography in post-orthotopic liver transplant population with roux-en-y biliary reconstruction. Liver Transpl 13:1168-73
16. Charlton M, Seaberg E, Wiesner R, et al (1998) Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 28:823-30
17. Charlton M, Ruppert K, Belle SH, et al (2004) Long-term results and modeling to predict outcomes in recipients with HCV infection. Liver Transpl 10:1120-30
18. Colle IO, Moreau R, Godinho E, et al (2003) Diagnosis of portopulmonary hypertension in candidates for liver transplantation. Hepatology 37:401-9
19. D'Alessandro AM, Ploeg RJ, Knechtle SJ, et al (1993) Retransplantation of the liver - a seven-year experience. Transplantation 55:1083-7
20. Deminclean, Noureddine, Vigos, et al (1964) Tentative d'homogreffe hepatique. Mem Acad Chir 90:177
21. Desai NM, Mange KC, Crawford MD, et al (2004) Predicting outcome after liver transplantation. Transplantation 77:99-106
22. Dickson RG, Terrault NA, Ishitani M, et al (2006) Protective antibody levels and dose requirements for IV5% Nabi hepatitis immune globulin combined with lamivudine in liver transplantation for hepatitis B induced end stage liver disease. Liver Transpl 12:124-33
23. Dumortier J, Bernard S, Bouffard Y, et al (2006) Conversion from tacrolimus to cyclosporine in liver transplanted patients with diabetes mellitus. Liver Transpl 12:659-64
24. Everhart JE, Beresford TP (1997) Liver transplantation for alcoholic liver disease. Liver Transpl Surg 3:220-6
25. Everson GT, Trotter J, Forman L, et al (2005) Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 42:255-62
26. Figueras J, Ibanez L, Ramos E, et al (2001) Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis. Liver Transpl 7:877-83
27. Fisher RA, Kulik LM, Freise CE, et al (2007) Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transpl 7:1601-8
28. Fishman JA, Emery V, Freeman R, et al (2007). Cytomegalovirus in transplantation-challenging the status quo. Clin Transpl 21:149-58
29. Freeman RB (2003) The impact of the model for end-stage liver disease on recipient selection for adult living donor liver donation. Liver Transpl 9:S54-S59
30. Freeman RB, Wiesner RH, Edwards E, et al (2004) Results of the first year of the new liver allocation plan. Liver Transpl 10:7-15
31. Fung J, Eghtesad B, Patel-Tom K, et al (2004) Liver transplantation in patients with HIV infection. Liver Transpl 10:S39-53
32. Guchelberger O, Bechstein WO, Neuhaus R, et al (1997) Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation. Clin Transpl 11:60-5
33. Heimbach JK, Haddock MG, Alberts SR, et al (2004) Transplantation for hilar cholangiocarcinoma. Liver Transpl 10:S65-8
34. Heisel O, Heisel R, Balshaw R, et al (2004) New onset diabetes mellitus in patients receiving calcineurin inhibitors. Am J Transpl 4:583-95
35. Hoppe L, Marroni CA, Bressane R, et al (2006) Risk factors associated with cytomegalovirus infection in orthotopic liver transplant patients. Transpl Proc 38:1922-3
36. Hopper C, Marroni CA, Bressare R, et al (2006) Impact of cytomegalovirus infection on long-term survival after orthotopic liver transplantation. Transpl Proc 38:1924-5
37. Husain S, Tollemar J, Dominguez EA, et al (2003) Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients. Transplantation 75:2023-9
38. International Panel (1997) Banff schema for grading liver allograft rejection. Hepatology 25:658-63
39. Iwesaki Y, Porter KA, Arend JR, et al (1967) The preparation and testing of horse antidog and antihuman antilymphoid plasma on serum and its protein factors. Surg Gynecol Obstet 124:1-24
40. John PR, Thuluvath PJ (2001) Outcome of liver transplantation in patients with diabetes mellitus. Hepatology 34:889-95
41. Jonas S, Bechstein WO, Steinmuller T, et al (2001) Vascular invasion and histopathologic grading to determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33:1080-6
42. Kamath PS, Wiesner RH, Malinchoc M, et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464-70
43. Kitazano MT, Qayyum A, Yeh BM, et al (2007) Magnetic resonance cholangiography of biliary structures after liver transplantation. J Magn Reson Imaging 25:1168-73
44. Klintmalm GB (1998) Liver transplantation for hepatocellular carcinoma. Ann Surg 228:479-90
45. Kobashigawa JA, Khasiske BL (1997) Hyperlipidemia in solid organ transplantation. Transplantation 66:331-8
46. Koch DG, Christiansen L, Lazarchick J, et al (2007) Posttransplantation lymphoproliferative disorder - the great mimic in liver transplantation. Liver Transpl 13:904-12
47. Laryea M, Watt KD, Molinari M, et al (2007) Metabolic syndrome and liver transplant recipients. Liver Transpl 13:1104-14
48. Lim JK, Keefe EB (2004) Liver transplantation for alcoholic liver disease. Liver Transpl 10:S31-8
49. Liu CL, Lam B, Lo CM (2003) Impact of right-lobe live donor liver transplantation on patients waiting for liver transplantation. Liver Transpl 9:863-9
50. Llovet JM, Fuster J, Bruix J, et al (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma. Hepatology 30:1434-40
51. Lo CM, Fan S, Liu C, et al (2004) The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 10:440-7
52. Longheval G, Vereerstraeten P, Thiry P (2003) Predictive models of short- and long-term survival in patients with survival in patients with nonbiliary cirrhosis. Liver Transpl 9:260-7
53. Lucey MR, Brown KA, Everson GT, et al (1997) Minimal criteria for placement of adults on the liver transplant waiting list. Liver Transpl Surg 3:628-37
54. Luther P, Baldwin Jr. P (2004) Pioglitazone in the management of diabetes mellitus after transplantation. Am J Transpl 4:2135-8
55. Macedo G, Lopes S, Barroso S, et al (2003) Implementation of screening and preventive strategies in liver transplant candidates [Abstract]. Transpl Proc 35:115
56. Mandell MS (2004) Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era. Liver Transpl 10:S54-8
57. Marcos A, Fisher RA, Ham JM, et al (2000) Liver regeneration and function in donor and recipient right lobe adult living donor liver transplantation. Transplantation 69:1375-9
58. Mazzaferro V, Regalia E, Doci R, et al (1996) Liver transplantation for hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 334:693-9
59. McDiarmid SV, Anand R, Lindblad AS, et al (2002) Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 74:173-81
60. Merion RM, Schaubel DE, Dykstra DM, et al (2005) The survival benefit of liver transplantation. Am J Transpl 5:307-13
61. Merion RM, Wolfe RA, Dykstra DM, et al (2003) Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 9:12-8
62. Mirabella S, Brunati A, Ricchiuti A, et al (2005) New-onset diabetes after liver transplantation. Transpl Proc 37:2636-7
63. Moore FD, Birtch AG, Dagher F, et al (1964) Immunosuppression and liver transplantation. Ann NY Acad Sci 120:729-38
64. Neal DA, Brown MJ, Wilkinson IB, et al (2005) Mechanisms of hypertension after liver transplantation. Transplantation 79:935-40
65. Neuberger J, Schulz KH, Day C, et al (2002) Treatment for alcoholic liver disease. J Hepatol 36:130-7
66. O'Grady J, Alexander GJ, Hayllar KM, et al (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97:439-45
67. Olthoff KM, Brown RS, Delmonico FL, et al (2004) Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. Liver Transpl 10:A6-22
68. Osawa M, Ito Y, Hirai T, et al (2007) Risk factors for invasive aspergillosis in living donor liver transplant recipients. Liver Transpl 13:566-70
69. Palumbo JD, Lopes SM, Zeisel SH, et al (1987) Effectiveness of orthotopic liver transplantation on the restoration of cholesterol metabolism in patients with end-stage liver disease. Gastroenterology 93:1170-7
70. Pappas PG, Andes D, Schuster M, et al (2006) Invasive fungal infections in low-risk liver transplant recipients. Am J Transpl 6:386-91
71. Pfau PR, Kochman ML, Lewis JD, et al (2000) Endoscopic management of postoperative liver transplantation. Gastrointest Endosc 52:55-63
72. Pugh R N H, Murray-Lion IM, Dawson JC, et al (1979) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:640-6
73. Ragni M, Belle SH, Im KA, et al (2003) Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 188:1412-20
74. Rea DJ, Heimbach JK, Rosen CB, et al (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242:451-8
75. Rerknimitr R, Sherman S, Fogel EL, et al (2002) Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis. Gastrointest Endosc 55:224-31
76. Rocca P, Cocuzza E, Rasetti R, et al (2003) Predictors of psychiatric disorders in liver transplantation candidates. Liver Transpl 9:721-6
77. Roy A, Kneteman N, Lilly L, et al (2006) Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant. Transplantation 82:494-500
78. Rubin RH, Wolfson JS, Cosimi AB, et al (1981) Infection in the renal transplant recipient. Am J Med 70:405-11
79. Russo MW, Galanko J, Beavers K, et al (2004) Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl 10:340-6
80. Russo MW, La Pointe-Rudow D, Kinkhabwala M, et al (2004) Impact of adult living donor liver transplantation on waiting time survival in candidates listed for liver transplantation. Am J Transpl 4:427-31
81. Safdar K, Neff GW, Montalbano M, et al (2004) Liver transplant for the septuagenarians. Transpl Proc 36:1445-8
82. Sala M, Fuster J, Llovet JM, et al (2004) High pathological risk of recurrence after surgical resection for hepatocellular carcinoma. Liver Transpl 10:1294-300
83. Sala M, Varela M, Bruix J (2004) Selection of candidates with hepatocellular carcinoma in the MELD era. Liver Transpl 10:S4-9
84. Saliba F, Lakehalm M, Pageaux GP, et al (2007) Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis c virus infection. Liver Transpl 13:136-44
85. Sato T, Inagaki A, Uchida K, et al (2003) Diabetes mellitus after transplant. Transplantation 76:1320-6
86. Sheiner PA, Magliocca JF, Bodian CA, et al (2000) Longterm medical complications in patients surviving = five years after liver transplant. Transplantation 69:781-9
87. Shimoda M, Farmer DG, Colquhoun SD, et al (2001) Liver transplantation for cholangiocellular carcinoma. Liver Transpl 7:1023-33
88. Silva MA, Jambulingam PS, Gunson BK, et al (2006) Hepatic artery thrombosis following orthotopic liver transplant. Liver Transpl 12:146-151
89. Singh N, Wagener MM, Obman A, et al (2004) Bacteremias in liver transplant recipients. Liver Transpl 10:844-9
90. Starzl TE, Marchioro TL, Vonkaulla KN, et al (1963) Homotransplantation of the liver in humans. Surg Gynecol Obstet 117:659-76
91. Starzl TE, Marchioro TL, Rowldand DT, et al (1964) Immunosuppression after experimental and clinical homotransplantation of the liver. Ann Surg 160:411-39
92. Starzl TE, Machioro TL, Porter KA, et al (1967) The use of heterologous antilymphoid agents in canine and in human renal homotransplantations. Surg Gynecol Obstet 124:301-8
93. Starzl TE, Murase M, Marcos M, et al (2005) History of liver and multivisceral transplantation. In: Bussuttil RW, Klintmalm GK (eds) Transplantation of the Liver. Elsevier Sanders, Philadelphia, PA
94. Steagall MD, Everson G, Schroter G, et al (1995) Metabolic complications after liver transplantation. Transplantation 60:1057-60
95. Trotter JF (2000) Selection of donors and recipients for living donor liver transplantation. Liver Transpl 6:S52-8
96. Trotter JF, Wachs M, Trouillot T, et al (2000) Evaluation of 100 patients for living donor liver transplantation. Liver Transpl 6:290-5
97. UNOS Policy 3 Appendix 3B http://www.unos.org/PoliciesandBylaws/policies/ docs/policy-15.doc
98. Veldt BJ, Lainé F, Guillygomarc'h A, et al (2002) Indications of liver transplantation in severe alcoholic liver cirrhosis. J Hepatol 36:93-8
99. Venook AP, Ferrell LD, Roberts JP (1995) Liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 4:242-8
100. Wiesner RM, McDiarmid SV, Kamath PS, et al (2001) Application of MELD and PELD to liver allocation. Liver Transpl 7:567-80
101. Yao FY, Ferrell L, Bass NM, et al (2001) Liver transplantation for hepatocellular carcinoma. Hepatology 33:1394-403
102. Yoo HY, Galabova V, Edwin D, et al (2002) Socioeconomic status does not affect the outcome of liver transplantation. Liver Transpl 8:1133-7
103. Yoo HY, Thuluvath PJ (2002) The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation 74:1007-12
104. Yoshida EM, Erb SR, Partovi N, et al (1999) Liver transplantation for chronic hepatitis B infection with the use of combination lamivuudine and low-dose hepatitis B immune globulin. Liver Transpl Surg 5:520-5
105. Zheng S, Chen Y, Liang T, et al (2006) Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B immunoglobulin prophylaxis. Liver Transpl 12:253-8